Product category:
Manufacturing orders, contracts, financial reports
News Release from: ATS Automation Tooling Systems
Edited by the Manufacturingtalk Editorial
Team on 01 March 2004
Global pharmaceutical company signs
$3.8m deal
ATS Automation Tooling Systems has been chosen as the single source provider of integrated automation manufacturing systems, valued at CDN $3.6 million, for a global pharmaceutical company.
ATS Automation Tooling Systems has announced that it has been chosen as the single source provider of integrated automation manufacturing systems - valued at CDN $3.6 million - for a global pharmaceutical company The assignment - comprised of three projects (two of which are largely duplicates) - reflects a level of single point automation integration not yet common in the pharmaceutical industry
This article was originally published on Manufacturingtalk on 17 Mar 2004 at 8.00am (UK)
Related stories
Aseptic robot withstands harsh sterilization
A prototype, ultra-clean, aseptic robot, believed to be the first automated robotic solution capable of withstanding the harsh sterilization treatment, will be shown at INTERPHEX 2004, USA.
Cost-effective assembly system installed
India based Avasarala Automation, has provided cost effective solution for a compressor assembly line for air-conditioner and refrigerator system.
As the single source provider, ATS will design, build and install these integrated lines that will be used by the customer to inspect and package several of the customer's liquid sterile drug products.
One of the lines will involve delivery of a new ATS automation system for high-speed inspection of form-fill-seal ampoules, adding to ATS's repertoire of standard machine vision platforms for pharmaceutical applications.
The systems are expected to be delivered by the end of calendar 2004.
Further reading
Nickel and cobalt producers buy latest automation
An enhanced automation system has been purchased by the world's leading producer and refiner of cobalt and the world's fifth largest producer of nickel.
Abac acquires ALUP Kompressoren
As part of a strategic investment in the European industrial market, ABAC, the world's largest manufacturer of compressed air systems, has acquired ALUP Kompressoren GmbH.
Air compressor distributor appointed
ABAC has appointed Eastern Compressors to represent both its ABAC and ALUP brands of high-performance air compressors and associated technology.
This adds to the Company's interim (5 weeks) fourth quarter new automation systems order bookings of $54 million announced February 5, 2004.
"This is the latest example of ATS's growing presence in pharmaceuticals, and our ability to develop and apply the best manufacturing technology available," said Klaus Woerner, ATS President and Chief Executive Officer.
"Our customer is making very innovative use of our capabilities, in fact fully automated material handling with integrated automated inspection for the customer's process may be an industry first.
This is a customer that values production efficiency and knows the best place to achieve it is ATS." Woerner added that the customer has elected to initiate FDA validation activities "while the lines are still on our assembly floor, saving both time and money.
Our ability to offer validation support early in the machine design and development process for a complex integrated manufacturing system is a distinct competitive advantage for ATS as a supplier to the sector." Demand for single source automation in this market is expected to grow in future in part because regulatory bodies require pharmaceutical companies to establish documented evidence providing a high degree of assurance that their facilities, processes and equipment will consistently produce a safe, high quality result and meet predetermined current Good Manufacturing Practices (cGMP).
Single source manufacturing automation not only provides the means to enhance quality and compliance with cGMP, but also leads to reduced overall installed costs, and improved throughput and delivery timeframes.
"Science has traditionally overshadowed manufacturing in the industry, but this is changing rapidly," said Woerner.
"A number of senior industry executives, as well as the FDA, have recently announced a shift in priorities to include greater production efficiencies and a focus on new manufacturing technologies.
Our ability to add value through turn key service and the most advanced approaches to manufacturing automation sets ATS apart in the pharmaceutical market." Pharmaceuticals and the broader healthcare industry represent a strategic focus for ATS.
Pharmaceuticals represent about two thirds of the $550 billion global healthcare product market, and this sector is expected to grow 12% annually over the next five years.
The name of the client and contract details cannot be disclosed due to confidentiality requirements.
• ATS Automation Tooling Systems: contact details and other news
• Email this article to a colleague
• Register for the free Manufacturingtalk email newsletter
• Manufacturingtalk Home Page
Search the Pro-Talk network of sites
